Solesence, Inc. (SLSN)
| Market Cap | 98.18M |
| Revenue (ttm) | 62.06M |
| Net Income (ttm) | 1.79M |
| Shares Out | 70.63M |
| EPS (ttm) | 0.02 |
| PE Ratio | 69.50 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 33,046 |
| Open | 1.380 |
| Previous Close | 1.390 |
| Day's Range | 1.272 - 1.390 |
| 52-Week Range | 0.780 - 5.630 |
| Beta | 1.17 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 12, 2026 |
About SLSN
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnost... [Read more]
Financial Performance
In 2025, Solesence's revenue was $62.06 million, an increase of 18.56% compared to the previous year's $52.35 million. Earnings were $1.79 million, a decrease of -57.73%.
Financial StatementsNews
Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12
ROMEOVILLE, Ill., April 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced ...
Solésence, Inc. Announces Appointment of New Independent Director
Marc James to Join Board of Directors and Serve on Audit, Compensation, and Nominating Committees ROMEOVILLE, Ill., April 27, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scien...
Solesence Earnings Call Transcript: Q4 2025
Revenue hit a record $62.1M in 2025, up 18.6% year-over-year, but margin compression limited profit growth. Operational improvements and the Transform and Transcend initiative aim to boost margins and EBITDA in 2026, with a 30% gross margin floor set.
Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results
Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beaut...
Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026
ROMEOVILLE, Ill., March 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced ...
Yoolie Park joins Solésence, Inc. as Vice President of Brand Partnerships
Park brings over 20 years of industry experience to expand innovation and drive brand partner growth ROMEOVILLE, Ill., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN) a leader in scie...
Solesence Earnings Call Transcript: Q3 2025
Q3 2025 saw a 14% revenue decline and a net loss, impacted by industry softness and operational inefficiencies, but full-year sales are up $10–12 million. Leadership changes, cost controls, and facility consolidation are expected to restore margins and drive future growth, with guidance for improved profitability and continued outperformance in mineral-based beauty.
Solésence Reports Third Quarter 2025 Financial Results
Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a lea...
Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity
Dvorzsak to oversee product quality and drive innovation to support growth amidst evolving consumer needs; Named a Cosmetic Executive Women (CEW) Innovator Honoree ROMEOVILLE, Ill., Nov. 10, 2025 (GLO...
Solésence To Report Third Quarter 2025 Financial Results and Host a Conference Call
ROMEOVILLE, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...
Solésence Announces Key Leadership Appointments to Drive Future Innovation and Growth
ROMEOVILLE, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced ...
Solesence Earnings Call Transcript: Q2 2025
Record Q2 revenue and profitability were driven by strong demand, operational efficiencies, and new partnerships. Despite expected demand moderation in the second half due to tariffs and seasonality, full-year revenue is projected to reach a new high.
Solésence Reports Second Quarter 2025 Financial Results
ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced f...
Solésence To Report Second Quarter 2025 Financial Results and Host a Conference Call
ROMEOVILLE, Ill., July 24, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...
Solésence to Join Russell 3000® and Russell 2000® Indexes
ROMEOVILLE, Ill., June 24, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...
Solésence Expands Debt Facilities to Fuel Growth Initiatives
ROMEOVILLE, Ill., June 02, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...
Solesence Earnings Call Transcript: Q1 2025
Record Q1 revenue grew nearly 50% year-over-year, driven by major product launches and strong demand, though margins were temporarily impacted by one-time startup costs. Gross margins are expected to rebound above 30% for the year, with continued top-line growth and operational improvements underway.
Solésence Reports Record First Quarter 2025 Financial Results
First quarter revenue increased 48% to a record $14.6 million ROMEOVILLE, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions...
Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call
ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life s...
Solésence Announces Uplisting to Nasdaq
Trading set to begin Tuesday, April 8 under new ticker “SLSN” ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solution...
Solesence Earnings Call Transcript: Q4 2024
Record 2024 revenue and net income were driven by strong demand, margin expansion, and operational improvements. Outlook for 2025 remains positive, with continued growth, new product launches, and Nasdaq uplisting plans, though risks from tariffs and inventory management persist.
Solésence Reports Record Fourth Quarter and Full-Year 2024 Financial Results
Fourth quarter revenue increased 58% to a record $12.6 million Full Year 2024 revenue increased 40% to a record $52.3 million ROMEOVILLE, Ill., March 26, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQ...
Solésence To Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call
ROMEOVILLE, Ill., March 20, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...
Solésence Wins Best Prestige Finished Formula at the 2025 Cosmetics & Toiletries Allē Awards, Marking Third Consecutive Win
ROMEOVILLE, Ill., March 13, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...
Solésence Launches New Investor Relations Website
ROMEOVILLE, Ill., March 12, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...